| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/09/2004 | US20040248895 Novel guanidino compounds |
| 12/09/2004 | US20040248893 Isoxazolopyridinones |
| 12/09/2004 | US20040248892 Low cost, simple, high yield and purity synthesis of indolo[2,3-a]pyrrolo[3,4-c]carbazoles; oxidative cyclization of bisindolylmaleimide compounds |
| 12/09/2004 | US20040248891 Imidazotriazinone-containing compositions for nasal administration |
| 12/09/2004 | US20040248890 Voltage gated sodium and calcium channel inhibitors |
| 12/09/2004 | US20040248889 Analgesics; synthesis |
| 12/09/2004 | US20040248887 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide |
| 12/09/2004 | US20040248886 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide |
| 12/09/2004 | US20040248885 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 12/09/2004 | US20040248883 Novel heteroaryl derivatives, their preparation and use |
| 12/09/2004 | US20040248881 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders |
| 12/09/2004 | US20040248879 Phosphate salt of 8-fluoro-2-(4-methylaminomethyl-phenyl)-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one; water solubility; potentiation of anticancer therapies; inhibition of neurotoxicity from stroke, head trauma and/or neurodegenerative diseases |
| 12/09/2004 | US20040248878 Lactam compound |
| 12/09/2004 | US20040248876 Reducing islet amyloid polypeptide (IAPP) associated deposit; type II diabetes |
| 12/09/2004 | US20040248875 Such as 7-[-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-carboxy-1-methylethoxyimino)acetamido]-3-[3-amino-4-(3-aminopropyl)-2-methyl-1-pyrazolio]methyl-3-cephem-4-carboxylate; antimicrobial agents; synthesis |
| 12/09/2004 | US20040248874 Anti-microbial composition comprising a metal ion chelating agent |
| 12/09/2004 | US20040248873 Photoreactive compounds and compositions |
| 12/09/2004 | US20040248870 High-purity composition comprising (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 12/09/2004 | US20040248868 Antiischemic agents; prevent damage to tissues, organs |
| 12/09/2004 | US20040248867 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
| 12/09/2004 | US20040248866 Mometasone furoate cream in oil; stability; bioavailability ; antiinflammatory agents |
| 12/09/2004 | US20040248865 Synergistic mixture containing antiinflammatory agents; rheumatic disorders |
| 12/09/2004 | US20040248864 Use of anthroquinones in the treatment of kidney disease |
| 12/09/2004 | US20040248863 Combination of a ppar-alpha ligand and glucocorticoid for the treatment or prevention of inflamation |
| 12/09/2004 | US20040248862 Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
| 12/09/2004 | US20040248861 Modified delta5-androstenes having improved bioavailability |
| 12/09/2004 | US20040248860 increasing testosterone concentration; sexual disorders |
| 12/09/2004 | US20040248859 Medicinal compositions for treating secondary parathyroid hyperfunction and remedies for cardiovascular complications in association with treatment for secondary parathyroid hyperfunction |
| 12/09/2004 | US20040248858 Applying salicylic acid to remove cancer |
| 12/09/2004 | US20040248854 Piperidinyl prostaglandin E analogs |
| 12/09/2004 | US20040248853 Antiinflammatory agents; antihistamines; adult respiratory distress syndrome; antidiabetic agents; inflammatory bowel disorders |
| 12/09/2004 | US20040248852 Chemical compounds |
| 12/09/2004 | US20040248850 Compounds for the treatment of HIV infection |
| 12/09/2004 | US20040248849 3-Aryl-A-oxy substituted propanoic acids and a process for their preparation |
| 12/09/2004 | US20040248848 Use of specific dose of fondaparinux sodium for the treatment of acs |
| 12/09/2004 | US20040248847 Neutralized with dextran; adjustment of ph; prevent eye damage |
| 12/09/2004 | US20040248846 Intranasal administration of triptans |
| 12/09/2004 | US20040248845 Hyaluronic acid in soft gel form |
| 12/09/2004 | US20040248844 Method for the treatment or prevention of Flavivirus infections using nucleoside analogues |
| 12/09/2004 | US20040248843 Process for the preparation of tablets comprising s-adenosylmethionine |
| 12/09/2004 | US20040248842 Complexes for transporting nucleic acid into eukaryotic higher-cells |
| 12/09/2004 | US20040248840 Oligomeric compounds for the modulation of ras expression |
| 12/09/2004 | US20040248839 RNAi targeting of viruses |
| 12/09/2004 | US20040248835 Administering by inhalation, injection or orally; Rna interference in vitro; genetic engineering |
| 12/09/2004 | US20040248833 Therapeutic delivery compositions and methods of use thereof |
| 12/09/2004 | US20040248832 Enhancement of transfection of dna into the liver |
| 12/09/2004 | US20040248831 Oligodeoxynucleic acid modified with (thio)phosphate |
| 12/09/2004 | US20040248830 Agents that regulate apoptosis |
| 12/09/2004 | US20040248825 Use of neuraminidase inhibitors to prevent flu associated bacterial infections |
| 12/09/2004 | US20040248822 Reducing, controlling weight gain; administering estrogen and, or androgen |
| 12/09/2004 | US20040248821 Administering bioflavoids with bromelin ; synergistic mixture |
| 12/09/2004 | US20040248820 Administering 2-phthalimidoglutaric acid; vision defects; antitumor agents; anticancer agents |
| 12/09/2004 | US20040248819 Administering fructose of fructose containing oligosaccharide |
| 12/09/2004 | US20040248818 Therapeutic agent for the use in reducing alcohol intoxication and reducing or eliminating the negative side effects associated with alcohol ingestion |
| 12/09/2004 | US20040248817 Therapy for cardiovascular disorders; hypotensive agents; congestive heart failure |
| 12/09/2004 | US20040248816 Symergistic mixture containing sumatriptan and hydrochloride salt of 1-(N-2-(3,5-dibromo)-N-((4-(3,4-dihydro-2H-oxoquinazolin-3-yl)-1-piperidinyl)carbonyl)tyrosyl-lysyl-4--(4-pyridinyl)piperazine |
| 12/09/2004 | US20040248813 Compounds and methods for the modulation of cd154 |
| 12/09/2004 | US20040248806 Compounds comprising an analgesic molecule linked to a vector that can vectorise said molecule through the hematoencephalic barrier and pharmaceutical compositions containing same |
| 12/09/2004 | US20040248801 Multivalent ligands which carry or display at least one recognition element (RE), for binding directly or indirectly to cells or other biological particles; applicable for creating scaffolds of chemical/biological species |
| 12/09/2004 | US20040248789 peptides/fusion inhibitors; |
| 12/09/2004 | US20040248788 preventing or delaying the onset by administration of growth hormone to a mammal predisposed to essential or primary hypertension; such as when subjected to intrauterine undernutrution |
| 12/09/2004 | US20040248772 yeast-derived ingredient having beta 1,3/1.6 glucan structure (IMMUTOL) or Norwegian Beta Glucan (TM); natural killer cell activating capabilities and tumor angiogenesis inhibiting capability by oral administration |
| 12/09/2004 | US20040248771 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect |
| 12/09/2004 | US20040248769 hydrolytic; inhibits arginyl endopeptidase or serine protease activity; air cleaner; fabric treatment |
| 12/09/2004 | US20040248763 Canine cardiac diet |
| 12/09/2004 | US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators |
| 12/09/2004 | US20040248296 HIV therapeutic |
| 12/09/2004 | US20040248278 Streptococcus expressing lymphocytic protein for use in prevention and treatment of insulin resistance, obesity, autism and attention deficit/hyperactivity disorders |
| 12/09/2004 | US20040248266 Method for production of archidonic acid |
| 12/09/2004 | US20040248257 Spleen expressed cell surface protein (SPLEX) for use in treatment and prevention autoimmunity, cancer, transplant rejection and inflammation |
| 12/09/2004 | US20040248233 Using propyl hydroxylase expression system to identify modulators which interfere with or prevent generation of hypoxic states; screening modulator for treatment and prevention of cell proliferative and thrombotic disorder |
| 12/09/2004 | US20040248207 Sodium channel regulators and modulators |
| 12/09/2004 | US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 12/09/2004 | US20040248155 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 12/09/2004 | US20040248099 Calcium-activated potassium channels; 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives act as inhibitors; gene knockout; skin disorders; psoriasis; wound healing |
| 12/09/2004 | US20040248078 Contacting osteoblast and osteocyte with either a glucocorticoid alone or in combination with test compound and comparing number of osteoblast and osteocyte undergoing apoptosis, lowered number of apoptotic cells indicates test compound is modulator of glucocorticoid induced osteoporosis |
| 12/09/2004 | US20040247715 Solvent extraction using water, alcohol, chloroform; antitumor, anticancer agents |
| 12/09/2004 | US20040247711 Process for the production of allicin |
| 12/09/2004 | US20040247709 Administering aloe vera extract including acemannan, 1-glutamine and 1-glycine to traet abdominal pain and cramping |
| 12/09/2004 | US20040247707 Seven major ingredients of "Pearl Blue", a topical pain relief cream or lotion: 1. Lidocaine HCL, 2. Trolamine Salicylate or asprin, 3. Aloe Vera, 4. Sweet Almond Oil, 5. Menthol, 6. Oil of Wintergreen Gaultheris procumbens, 7. Tea Tree Oil Melaleuca |
| 12/09/2004 | US20040247706 Transdermal dietary supplement comprising parthenolide |
| 12/09/2004 | US20040247705 Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
| 12/09/2004 | US20040247704 Atractylis ovata Thunb, for effects of dehumidifying, sweating, protecting stomach and spleen so to help digestion, facilitate urination, cure dropsy and promote sweating; Poria cocoa Wolf, containing tuckahoe, glucose and oligosaccharide, giving tranquilizing effect, facilitating urination |
| 12/09/2004 | US20040247703 Composition for inhibiting glutamate-mediated neurotoxicity comprising ginsenoside Rg3 or ginsenoside Rh2 |
| 12/09/2004 | US20040247702 Caralluma extract products and processes for making the same |
| 12/09/2004 | US20040247701 Fagopyrum cymosum (Trev.) meisn composition, method to prepare and analyze the same and uses thereof |
| 12/09/2004 | US20040247700 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 12/09/2004 | US20040247693 Modifying the fatty acid composition of cell membranes of organs and tissues |
| 12/09/2004 | US20040247686 Pharmaceutical compositions comprising epinastine for the treatment of skin diseases |
| 12/09/2004 | US20040247685 the hydrogel contains a synergistic emollient mixture of octoxyglycerin, a quaternary ammonium compound, and an antimicrobial agent; enhanced rapid and long-term antimicrobial efficacy |
| 12/09/2004 | US20040247683 Aminoglucosides, such as streptomycin; oral dosage form; tuberculosis |
| 12/09/2004 | US20040247681 An acrylated polypropylene glycol or 1,2-propylene oxide adduct copolymerized with an acrylic silyl ester or an acrylic ketone; controlled release ocular inserts; glaucoma, cataracts |
| 12/09/2004 | US20040247679 Formulation of an active agent such as antibiotic, a water soluble or water swellable polymer, and an acid in given amounts; zero order release profile; extended release oral dosage forms |
| 12/09/2004 | US20040247676 The active and barrier layers each contain two or more hydrophilic polymers, a lipophilic substance, and an adjuvant; side effect reduction; single daily dosage |
| 12/09/2004 | US20040247674 Drug delivery system |
| 12/09/2004 | US20040247673 Wet granulated particle form; compression; milling; benign prostate hyperplasia ; anticholesterol agents; antilipemic agents; Alzheimer's disease |
| 12/09/2004 | US20040247667 Novel compound |
| 12/09/2004 | US20040247666 Prompt-release formulations containing an active ingredient solubilised, suspended or embedded in an amphiphilic matrix; improved pharmacokinetics |
| 12/09/2004 | US20040247659 (Ester)-lysolecithins in liposomes |
| 12/09/2004 | US20040247658 Delivery system with increased bioavailability |